Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Elisa Genuardi, Marios Papadimitriou, Benjamin Diamond, Paolo Corradini, David Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura, Alessandra Larocca
doi: https://doi.org/10.1101/2023.12.04.23299287
Bachisio Ziccheddu
1Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA
Claudia Giannotta
2Laboratory of Blood Tumor Immunology, Molecular Biotechnology Center “Guido Tarone”, Department of Molecular Biotechnology and Health Sciences, Università di Torino, Torino, Italy
Mattia D’Agostino
3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Giuseppe Bertuglia
3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Elona Saraci
3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Stefania Oliva
3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Elisa Genuardi
3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Marios Papadimitriou
1Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA
Benjamin Diamond
1Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA
Paolo Corradini
4Division of Hematology and Bone Marrow Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
David Coffey
1Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA
Ola Landgren
1Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA
Niccolò Bolli
5Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
6Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy
Benedetto Bruno
3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Mario Boccadoro
3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Massimo Massaia
2Laboratory of Blood Tumor Immunology, Molecular Biotechnology Center “Guido Tarone”, Department of Molecular Biotechnology and Health Sciences, Università di Torino, Torino, Italy
7SC Ematologia, AO S. Croce e Carle, Cuneo, Italy
Francesco Maura
1Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA
Alessandra Larocca
3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Posted December 04, 2023.
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Elisa Genuardi, Marios Papadimitriou, Benjamin Diamond, Paolo Corradini, David Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura, Alessandra Larocca
medRxiv 2023.12.04.23299287; doi: https://doi.org/10.1101/2023.12.04.23299287
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Elisa Genuardi, Marios Papadimitriou, Benjamin Diamond, Paolo Corradini, David Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura, Alessandra Larocca
medRxiv 2023.12.04.23299287; doi: https://doi.org/10.1101/2023.12.04.23299287
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2880)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12614)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4480)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (378)
- HIV/AIDS (909)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4242)
- Nursing (228)
- Nutrition (621)
- Oncology (2225)
- Ophthalmology (632)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (487)
- Public and Global Health (6827)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (374)
- Surgery (475)
- Toxicology (60)
- Transplantation (204)
- Urology (175)